JGC
BIOA.WS

J. Goldman & Co’s BioAmber Inc. BIOA.WS Stock Holding History

J. Goldman & Co’s Portfolio BIOA.WS Stock Details BIOA.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-120,100
Closed -$96K – 369
2013
Q3 		$96K Sell
120,100
-200
-0.2% -$149 0.01% 248
2013
Q2 		$66K Buy
+120,300
New +$76.3K 0.01% 237

Other funds holding BIOA.WS

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

J. Goldman & Co's BIOA.WS Position: Q4 2013 in Review

J. Goldman & Co sold out of BioAmber Inc. (BIOA.WS) in Q4 2013, closing a stake of 120,100 shares — an estimated $96K sold.

J. Goldman & Co first reported a position in BIOA.WS in Q2 2013 and held it in 2 quarters. The position peaked at $96K in Q3 2013. 11 funds tracked by Wall St. Rank hold BIOA.WS as of Q4 2013.

  • J. Goldman & Co reported no remaining BioAmber Inc. position as of Q4 2013 after selling out during the quarter.
  • J. Goldman & Co sold 120,100 BioAmber Inc. shares in Q4 2013, an estimated $96K.
  • J. Goldman & Co first reported a position in BioAmber Inc. in Q2 2013 and held it in 2 quarters.
  • J. Goldman & Co's BioAmber Inc. position peaked at $96K in Q3 2013.
  • 11 funds tracked by Wall St. Rank held BioAmber Inc. as of Q4 2013.

Based on J. Goldman & Co's 13F filing for Q4 2013, filed 14 Feb 2014.